Glidepath

GlidePath is a value-based oncology company founded by prominent biotechnology executives Lonnie Moulder and Mary Lynne Hedley, the founders of Tesaro. The company provides a specialized platform and clinical services designed to help oncology practices transition from traditional fee-for-service models to value-based care arrangements, such as the Oncology Care Model (OCM). GlidePath's business model focuses on improving patient outcomes and reducing the total cost of cancer care through data-driven care coordination, clinical pathways, and enhanced patient engagement. By providing the necessary infrastructure and expertise, GlidePath enables independent oncology practices to succeed in risk-based payment environments while maintaining high standards of clinical excellence.